Gainers
- Microbot Medical MBOT stock rose 152.0% to $3.1 during Monday's regular session. As of 13:30 EST, Microbot Medical's stock is trading at a volume of 129.7 million, which is 253555.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $25.2 million. As per the press release, Q1 earnings came out 3 days ago.
- Hepion Pharmaceuticals HEPA shares moved upwards by 83.02% to $16.24. Hepion Pharmaceuticals's stock is trading at a volume of 11.1 million shares as of 13:30 EST. This is 61474.2% of its average full-day volume over the last 100 days. The company's market cap stands at $61.9 million.
- Avrobio AVRO stock increased by 54.81% to $1.2. The current volume of 73.3 million shares is 11998.2% of Avrobio's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $52.9 million.
- Atea Pharmaceuticals AVIR stock increased by 33.91% to $4.96. Trading volume for this security as of 13:30 EST is 5.5 million, which is 935.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $413.2 million.
- MultiPlan MPLN shares increased by 27.6% to $1.29. The current volume of 1.8 million shares is 98.1% of MultiPlan's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $846.0 million.
- Recursion Pharmaceuticals RXRX stock moved upwards by 26.9% to $8.16. Recursion Pharmaceuticals's stock is trading at a volume of 12.6 million shares as of 13:30 EST. This is 1009.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.5 billion.
Losers
- Rain Oncology RAIN shares fell 86.7% to $1.32 during Monday's regular session. As of 13:30 EST, this security is trading at a volume of 25.1 million shares, making up 13260.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $47.9 million.
- Mallinckrodt MNK stock declined by 44.93% to $3.47. Trading volume for Mallinckrodt's stock is 4.7 million as of 13:30 EST. This is 384.1% of its average full-day volume over the last 100 days. The company's market cap stands at $45.7 million.
- Intercept Pharma ICPT stock declined by 28.4% to $9.71. As of 13:30 EST, Intercept Pharma's stock is trading at a volume of 6.5 million, which is 726.9% of its average full-day volume over the last 100 days. The company's market cap stands at $404.7 million.
- Bluejay Diagnostics BJDX stock decreased by 18.15% to $0.22. Bluejay Diagnostics's stock is trading at a volume of 364.7K shares as of 13:30 EST. This is 358.8% of its average full-day volume over the last 100 days. The company's market cap stands at $4.5 million.
- Enveric Biosciences ENVB shares declined by 16.95% to $2.94. The current volume of 1.1 million shares is 53.8% of Enveric Biosciences's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $6.1 million.
- Sigilon Therapeutics SGTX shares declined by 16.75% to $0.53. The current volume of 135.1K shares is 62.7% of Sigilon Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $17.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in